IF YOU HAVE ANY DOUBT about how important CME guidelines are to the government, check out the Office of Inspector General's new guidance for pharmaceutical manufacturers, at www.oig.hhs.gov, issued as we went to press. Emphasizing that pharma firms should keep their hands off CME content development and faculty choices, it says “codes of conduct promulgated by the CME industry may provide a useful starting point for manufacturers when reviewing their CME arrangements.” (Watch for the ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.